Reveal LINQ vs Volta AF-Xplorer
AI Verdict
Choose Reveal LINQ if…
Choose Reveal LINQ if you require long-term, continuous cardiac monitoring for diagnostic purposes, particularly for patients experiencing infrequent or unexplained arrhythmias such as cryptogenic stroke, unexplained syncope, or suspected atrial fibrillation. Its implantable nature and AI-powered detection allow for up to three years of accurate ECG recording, capturing events that might be missed by shorter-term monitoring solutions.
View Reveal LINQ →Choose Volta AF-Xplorer if…
Choose Volta AF-Xplorer if you are performing electrophysiology ablation procedures for complex atrial fibrillation or atrial tachycardia and need real-time, AI-assisted guidance to identify optimal ablation targets. This system helps clinicians by automatically detecting and annotating dispersed electrograms, providing critical decision support during the procedure to improve treatment efficacy.
View Volta AF-Xplorer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ | Volta AF-Xplorer |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. | Software, integrated with existing electrophysiology lab hardware (e.g., EP recording systems, 3D navigation systems, mapping catheters). |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Reveal LINQReveal LINQ (Tool A) offers a minimally invasive insertion procedure and a user-friendly system for both patients (bedside monitor) and clinicians (mobile app for management). Its focus on simplifying long-term, passive monitoring across the patient journey gives it an edge. Volta AF-Xplorer (Tool B) provides a simple UI for clinicians, but operates within the inherently complex environment of an electrophysiology lab.
Clinical Value
Volta AF-XplorerVolta AF-Xplorer (Tool B) provides real-time AI-assisted guidance during complex electrophysiology ablation procedures, directly impacting the efficacy and precision of an intervention for challenging arrhythmias. While Reveal LINQ (Tool A) offers significant diagnostic value through long-term monitoring and reduced false alerts, Tool B's immediate impact on procedural success for complex AF/AT represents a distinct clinical advantage in treatment outcomes.
Pricing & Value
TieBoth tools explicitly state 'contact vendor for pricing,' which is standard for specialized medical devices. Neither provides public pricing details, making it impossible to assess or compare their value propositions based on cost. Both are likely covered by insurance given their FDA clearance and medical device status.
Enterprise Readiness
Reveal LINQMedtronic (Tool A's company) is a global leader in medical technology with extensive infrastructure, established relationships with healthcare systems, and a robust support ecosystem. While Volta Medical (Tool B) is FDA-cleared and HIPAA compliant, Medtronic's long-standing presence and comprehensive enterprise capabilities likely make Reveal LINQ more readily integrated and supported within large healthcare organizations.
Innovation
Volta AF-XplorerVolta AF-Xplorer (Tool B) demonstrates a higher degree of innovation by applying AI in real-time during a complex interventional procedure to guide treatment for challenging atrial fibrillation and tachycardia. This direct, real-time AI assistance during an active surgical intervention is a more novel application compared to Reveal LINQ's (Tool A) innovation in device miniaturization and AI for diagnostic accuracy and false alert reduction.
Support & Docs
Reveal LINQAs a product of Medtronic, a global medical device giant, Reveal LINQ (Tool A) benefits from the company's extensive resources for support, training, and comprehensive documentation. While Volta Medical (Tool B) undoubtedly provides adequate support for its specialized product, it is unlikely to match the breadth and depth of resources available from a company of Medtronic's scale.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ | Volta AF-Xplorer |
|---|---|---|
| Tool Name | Reveal LINQ | Volta AF-Xplorer |
| Company | Medtronic | Volta Medical |
| Primary Function Summary | Tiny, implantable cardiac monitor for continuous ECG recording and AI-powered arrhythmia detection and diagnosis. | AI-assisted mapping and decision-support system for electrophysiology ablation procedures, detecting dispersed electrograms in real-time. |
| Target Medical Specialties | Cardiology, Neurology | Cardiology |
| Key AI-Powered Functionality | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause) and accurate detection/diagnosis of cardiac arrhythmias. | AI-assisted mapping and decision-support system for EP ablation procedures, real-time detection and annotation of dispersed electrograms (EGMs), automated tagging of regions of interest. |
| Core Application/Focus | Continuous ECG monitoring for up to three years for diagnosis of cardiac arrhythmias (e.g., atrial fibrillation, cryptogenic stroke, unexplained syncope). | Guiding treatment for complex atrial fibrillation and atrial tachycardia during ablation procedures. |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ and Volta AF-Xplorer.